Abstract
Melanoma is one of the most vigorous and life threatening kind of skin cancer, accounting for millions of death per year. Understanding the process of normal cells transforming to melanoma cells has become a current necessity. The prime objective of the study is to classify the mutated genes that have a role in transforming normal skin epithelial cells into a melanoma cell and predicting their clinical relevance and health care perspective. In order to achieve the objective, we have conducted a comprehensive genome analysis using whole exome sequencing data, precisely focusing on mutations or gene alterations at distinct stages of melanoma. The high number of mutations was predicted at the metastatic stage on conducting whole exome sequence data analysis, wherein study showed that among 61 genes involved in melanoma process, majority of genes are part of NF-KB and WNT signaling pathway, thereby hints the involvement of these two pathways in melanoma disease progression. The identified genes are OR52E2, OR51I1, OR52A5, OR5AS1, OR52E6, OR10P1, OR5M1, OR10A7, OR9Q2, OR52I1, RASA1, and PIK3CA. Further, Invitro analysis of these genes may prove the possibility of melanoma biomarkers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
R. Siegel, K. Miller, A. Jemal, Cancer statistics, 2018. CA: A Cancer J. Clin. 68, 7–30 (2018)
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline. https://www.ncbi.nlm.nih.gov/pubmed/2736729
P. Das, N. Deshmukh, A review article on melanoma. J. Pharm. Sci. Res. 8(2), 112–117 (2016)
C.J. Kim, D.S. Reintgen, The new melanoma staging system. Cancer Control 9, 9–15 (2002)
J.R. Gloster, M. Hugh, K. Neal, Skin cancer in skin of color. J. Am. Acad. Dermatol. 55(5), 741–760 (2006)
A. Goldstein, M. Tucker, Genetic epidemiology of cutaneous melanoma. Arch. Dermatol. 137, 11 (2001)
P.T. Bradford, Skin cancer in skin of color. Dermatol. Nurs./Dermatol. Nurs.’ Assoc. 21(4), 170 (2009)
C. DeSantis, Cancer treatment and survivorship statistics, 2014. CA: A Cancer J. Clin. 64, 252–271 (2014)
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. https://www.ncbi.nlm.nih.gov/pubmed/11504744
C. Grin, Accuracy in the clinical diagnosis of malignant melanoma. Arch. Dermatol. 126, 763 (1990)
N. Pakseresht, B. Alako, C. Amid, A. Cerdeño-Tárraga, I. Cleland, R. Gibson, R. Leinonen, Assembly information services in the European Nucleotide Archive. Nucleic Acids Res. 42, 38–43 (2013)
Babraham Bioinformatics—FastQC A Quality Control tool for High Throughput Sequence Data. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/
F. Hsu, W. Kent, H. Clawson, R. Kuhn, M. Diekhans, D. Haussler, The UCSC known Genes. Bioinformatics 22, 1036–1046 (2006)
B. Langmead, S.L. Salzberg, Fast gapped-read alignment with Bowtie 2. Nat. Methods 9(4), 357 (2012)
G.J. Etherington, R.H. Ramirez-Gonzalez, D. MacLean, bio-samtools 2: a package for analysis and visualization of sequence and alignment data with SAMtools in Ruby. Bioinformatics 31(15), 2565–2567 (2015)
A. McKenna, The Genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20(9), 1297–1303 (2010)
P.C. Ng, S. Henikoff, Accounting for human polymorphisms predicted to affect protein function. Genome Res. 12(3), 436–446 (2002)
D. Wei Huang, B.T. Sherman, Q. Tan, J.R. Collins, W.G. Alvord, J. Roayaei, R.A. Lempicki, The DAVID Gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 8(9), 1–16 (2007)
H. Mi, P. Thomas, PANTHER pathway: an ontology-based pathway database coupled with data analysis tools. Protein Netw. Pathw. Anal.123–140 (2009)
A. Hamosh, A.F. Scott, J. Amberger, D. Valle, V.A. McKusick, Online Mendelian inheritance in man (OMIM). Hum. Mutat. 15(1), 57–61 (2000)
S. Bamford, E. Dawson, S. Forbes, J. Clements, R. Pettett, A. Dogan, R. Wooster, The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br. J. Cancer 91(2), 355 (2004)
D. Zhi, R. Chen, Statistical guidance for experimental design and data analysis of mutation detection in rare monogenic mendelian diseases by exome sequencing. PLoS One 7(2), e31358 (2012)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this paper
Cite this paper
Biradar, S., Kiran Kumar, K.M., Naveen Kumar, M., Babu, R.L. (2020). Identification of Clinical Variants Present in Skin Melanoma Using Exome Sequencing Data. In: Jyothi, S., Mamatha, D., Satapathy, S., Raju, K., Favorskaya, M. (eds) Advances in Computational and Bio-Engineering. CBE 2019. Learning and Analytics in Intelligent Systems, vol 16. Springer, Cham. https://doi.org/10.1007/978-3-030-46943-6_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-46943-6_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-46942-9
Online ISBN: 978-3-030-46943-6
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)